Podcasts Other Learning With Lowell 40: Computational Antibody Drug Discovery Platform with Machine Learning Startup, Antiverse, with the Co-Founder Murat Tunaboylu

40: Computational Antibody Drug Discovery Platform with Machine Learning Startup, Antiverse, with the Co-Founder Murat Tunaboylu

Published: June 26, 2018, 4:19 p.m.

Machine Learning, Antibodies, and Drug discovery. Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody...

The post 40: Computational Antibody Drug Discovery Platform with Machine Learning Startup, Antiverse, with the Co-Founder Murat Tunaboylu first appeared on Learning With Lowell.